Different sizes of centrilobular ground-glass opacities in chest high-resolution computed tomography of patients with pulmonary veno-occlusive disease and patients with pulmonary capillary hemangiomatosis

Cardiovascular Pathology

Volumn 22, Issue 4, 2013, Pages 287-293

  Miura, Aya ^a   Akagi, Satoshi ^a   Nakamura, Kazufumi ^a   Ohta Ogo, Keiko ^b   Hashimoto, Katsushi ^a   Nagase, Satoshi ^a   Kohno, Kunihisa ^a   Kusano, Kengo ^a   Ogawa, Aiko ^c   Matsubara, Hiromi ^c   Toyooka, Shinichi ^a   Oto, Takahiro ^a   Ohtsuka, Aiji ^a   Ohe, Tohru ^a   Ito, Hiroshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION OKAYAMA MEDICAL CENTER   (Japan)

Author keywords

Centrilobular ground glass opacity; Computed tomography; Pulmonary capillary hemangiomatosis; Pulmonary hypertension; Pulmonary veno occlusive disease

Indexed keywords

ADULT; ARTICLE; AUTOPSY; BLOOD VESSEL DIAMETER; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; PULMONARY CAPILLARY HEMANGIOMATOSIS; PULMONARY HYPERTENSION; PULMONARY VENO-OCCLUSIVE DISEASE;

CENTRILOBULAR GROUND-GLASS OPACITY; COMPUTED TOMOGRAPHY; PULMONARY CAPILLARY HEMANGIOMATOSIS; PULMONARY HYPERTENSION; PULMONARY VENO-OCCLUSIVE DISEASE;

ADOLESCENT; ADULT; AUTOPSY; CAPILLARIES; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMANGIOMA, CAPILLARY; HUMANS; HYPERTENSION, PULMONARY; IMAGING, THREE-DIMENSIONAL; LUNG; LUNG NEOPLASMS; LUNG TRANSPLANTATION; MALE; PREDICTIVE VALUE OF TESTS; PULMONARY VENO-OCCLUSIVE DISEASE; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; REPLICA TECHNIQUES; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84879887357     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2012.12.002     Document Type: Article

References (27)

1. G. Simonneau, I.M. Robbins, M. Beghetti, R.N. Channick, M. Delcroix, and C.P. Denton Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 1 Suppl 2009 S43 S54
2. N. Galie, M.M. Hoeper, M. Humbert, A. Torbicki, J.L. Vachiery, and J.A. Barbera Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Respir J 34 6 2009 1219 1263
3. Y. Fukumoto, and H. Shimokawa Recent progress in the management of pulmonary hypertension Circ J 75 8 2011 1801 1810
4. D. Montani, L. Achouh, P. Dorfmuller, J. Le Pavec, B. Sztrymf, and C. Tcherakian Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology Medicine (Baltimore) 87 4 2008 220 233
5. G.G. Pietra, F. Capron, S. Stewart, O. Leone, M. Humbert, and I.M. Robbins Pathologic assessment of vasculopathies in pulmonary hypertension J Am Coll Cardiol 43 12 Suppl S 2004 25S 32S (Pubitemid 38759714)
6. A.A. Frazier, T.J. Franks, T.L. Mohammed, I.H. Ozbudak, and J.R. Galvin From the Archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis Radiographics 27 3 2007 867 882
7. R.J. Barst, L.J. Rubin, W.A. Long, M.D. McGoon, S. Rich, and D.B. Badesch A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group N Engl J Med 334 5 1996 296 302
8. M. Humbert, O. Sitbon, A. Chaouat, M. Bertocchi, G. Habib, and V. Gressin Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era Circulation 122 2 2010 156 163
9. D. Montani, X. Jais, L.C. Price, L. Achouh, B. Degano, and O. Mercier Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease Eur Respir J 34 6 2009 1348 1356
10. A. Ogawa, K. Miyaji, I. Yamadori, Y. Shinno, A. Miura, and K.F. Kusano Safety and efficacy of epoprostenol therapy in pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis Circ J 76 7 2012 1729 1736
11. D. Montani, L.C. Price, P. Dorfmuller, L. Achouh, X. Jais, and A. Yaici Pulmonary veno-occlusive disease Eur Respir J 33 1 2009 189 200
12. E.J. Barbosa Jr., N.K. Gupta, D.A. Torigian, and W.B. Gefter Current role of imaging in the diagnosis and management of pulmonary hypertension AJR Am J Roentgenol 198 6 2012 1320 1331
13. A. Miura, K. Nakamura, K.F. Kusano, H. Matsubara, A. Ogawa, and S. Akagi Three-dimensional structure of pulmonary capillary vessels in patients with pulmonary hypertension Circulation 121 19 2010 2151 2153
14. M. Remy-Jardin, J. Remy, F. Giraud, L. Wattinne, and B. Gosselin Computed tomography assessment of ground-glass opacity: semiology and significance J Thorac Imaging 8 4 1993 249 264 (Pubitemid 23295490)
15. M. Remy-Jardin, F. Giraud, J. Remy, M.C. Copin, B. Gosselin, and A. Duhamel Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation Radiology 189 3 1993 693 698 (Pubitemid 23354479)
16. A. Resten, S. Maitre, M. Humbert, A. Rabiller, O. Sitbon, and F. Capron Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease AJR Am J Roentgenol 183 1 2004 65 70 (Pubitemid 38789013)
17. T. Murakami Application of the scanning electron microscope to the study of the fine distribution of the blood vessels Arch Histol Jpn 32 5 1971 445 454
18. A. Ogawa, K. Nakamura, H. Matsubara, H. Fujio, T. Ikeda, and K. Kobayashi Prednisolone inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension Circulation 112 12 2005 1806 1812 (Pubitemid 41368157)
19. K. Nakamura, J. Shimizu, N. Kataoka, K. Hashimoto, T. Ikeda, and H. Fujio Altered nano/micro-order elasticity of pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension Int J Cardiol 140 1 2010 102 107
20. K. Nakamura, S. Akagi, A. Ogawa, K.F. Kusano, H. Matsubara, and D. Miura Pro-apoptotic effects of imatinib on PDGF-stimulated pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension Int J Cardiol 159 2 2012 100 106
21. K. Hashimoto, K. Nakamura, H. Fujio, K. Miyaji, H. Morita, and K. Kusano Epoprostenol therapy decreases elevated circulating levels of monocyte chemoattractant protein-1 in patients with primary pulmonary hypertension Circ J 68 3 2004 227 231 (Pubitemid 38405014)
22. B. Dufour, S. Maitre, M. Humbert, F. Capron, G. Simonneau, and D. Musset High-resolution CT of the chest in four patients with pulmonary capillary hemangiomatosis or pulmonary venoocclusive disease AJR Am J Roentgenol 171 5 1998 1321 1324 (Pubitemid 28489421)
23. M. El-Gabaly, C.F. Farver, M.A. Budev, and T.L. Mohammed Pulmonary capillary hemangiomatosis imaging findings and literature update J Comput Assist Tomogr 31 4 2007 608 610 (Pubitemid 47457680)
24. J. Collins, and E.J. Stern Ground-glass opacity at CT: the ABCs AJR Am J Roentgenol 169 2 1997 355 367 (Pubitemid 27334842)
25. S. Akagi, K. Nakamura, K. Miyaji, A. Ogawa, K.F. Kusano, and H. Ito Marked hemodynamic improvements by high-dose epoprostenol therapy in patients with idiopathic pulmonary arterial hypertension Circ J 74 2010 2200 2205
26. A. Resten, S. Maitre, M. Humbert, O. Sitbon, F. Capron, and G. Simoneau Pulmonary arterial hypertension: thin-section CT predictors of epoprostenol therapy failure Radiology 222 3 2002 782 788 (Pubitemid 34215230)
27. D. Montani, D.S. O'Callaghan, L. Savale, X. Jais, A. Yaici, and S. Maitre Pulmonary veno-occlusive disease: recent progress and current challenges Respir Med 104 Suppl. 1 2010 S23 S32